Apax/WCAS Funds Price 10M InnovAge Share Sale at $9.25
INNV has more than doubled off its 52-week low of $3.935.
Summary
The controlling shareholder's secondary offering of 10 million shares has been priced at $9.25, a 4.1% discount to the last close of $9.65. The sale is entirely by Apax Partners and Welsh Carson affiliated funds, with a 30-day option for an additional 1.5 million shares. InnovAge receives no proceeds and will bear administrative costs. The transaction is expected to close September 24, 2026. This follows the S-3 shelf filing in July and the 424B7 prospectus filed yesterday; the pricing provides concrete terms for the previously announced sale. The discount is modest, suggesting reasonable demand, but the overhang from a large block sale may pressure the stock near term.
At the time of this announcement, INNV was trading at $9.65 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $3.94 to $12.64. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.